Latest News & Features
Asia-Pacific
China has launched an IP rights protection centre aimed at providing protection for the biopharmaceutical and high-end manufacturing industries. 2 August 2017
Americas
Sheppard, Mullin, Richter & Hampton has hired Kandace Watson, a lawyer with experience representing companies in complex transactions in IP-intensive industries. 2 August 2017
Americas
Bristol-Myers Squibb (BMS) has taken AstraZeneca to court over the alleged infringement of a patent for cancer treatment. 1 August 2017
Asia-Pacific
Takeda has entered into an exclusive licensing agreement with biopharmaceutical company Tesaro to develop a novel cancer therapy in Japan. 1 August 2017
Americas
The University of California, Berkeley has filed a brief at the US Court of Appeals for the Federal Circuit in its appeal against a patent decision on the CRISPR/Cas9 technology. 31 July 2017
Americas
AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza. 31 July 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of a lower court that found a patent owned by Regeneron unenforceable because of the biotech company’s inequitable conduct. 28 July 2017
Americas
The US International Trade Commission has begun an investigation into Fujifilm over certain X-ray breast imaging devices. 28 July 2017
Big Pharma
A European Patent Office Board of Appeal has published its decision that invalidated a patent owned by Bristol-Myers Squibb (BMS) which covered a blockbuster anti-cancer drug. 27 July 2017
Americas
GSK has revealed plans to cut back on research and development (R&D), while Eli Lilly announced a plan to focus its R&D resources on oncology. 27 July 2017